Frequency: Administer one subcutaneous injection daily for length of cycle
instead, it targets the skin surface and the layers above it
similar mechanisms may apply
Seek urgent or emergency medical care for difficulty breathing, swelling of the face or throat, fainting, a severe allergic reaction or another potentially life-threatening symptom
F., Vangilder, J., Lee-Ambrose, L., & Martin, F
What exists is: In-vitro CYP3A4 inhibition data for rhodiola constituents 4 5 Clinical BP-lowering data for rhodiola from small trials 6 Well-established CYP3A4 dependence for amlodipine clearance 1 2 Extrapolated risk based on analogous CYP3A4-substrate interactions with other weak inhibitors 22 What does not yet exist is a randomized crossover pharmacokinetic study measuring amlodipine AUC and Cmax with and without rhodiola co-administration